638
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Bioavailable serum estradiol may alter radiation risk of postmenopausal breast cancer: a nested case-control study

, , , , , , , , & show all
Pages 97-105 | Received 15 Sep 2017, Accepted 11 Dec 2017, Published online: 16 Jan 2018

References

  • Akahoshi M, Amasaki Y, Soda M, Hida A, Imaizumi M, Nakashima E, Maeda R, Seto S, Yano K. 2003. Effects of radiation on fatty liver and metabolic coronary risk factors among atomic bomb survivors in Nagasaki. Hypertens Res. 26:965–970.
  • Bauer S, Gusev BI, Pivina LM, Apsalikov KN, Grosche B. 2005. Radiation exposure due to local fallout from Soviet atmospheric nuclear weapons testing in Kazakhstan: solid cancer mortality in the Semipalatinsk historical cohort, 1960–1999. Radiat Res. 1641:409–419.
  • Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-Mesquita HB, Johnsen SP, Overvad K, Olsen A, et al. 2005. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 16:561–572.
  • Boice JD Jr, Preston D, Davis FG, Monson RR. 1991. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res. 125:214–222.
  • Brooks JD, Boice JD Jr, Stovall M, Reiner AS, Bernstein L, John EM, Lynch CF, Mellemkjaer L, Knight JA, Thomas DC, et al. 2012. Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 84:917–924.
  • Carmichael A, Sami AS, Dixon JM. 2003. Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation. Eur J Surg Oncol. 29:475–479.
  • Cologne JB, Pawel DJ, Sharp GB, Fujiwara S. 2004. Uncertainty in estimating probability of causation in a cross-sectional study: joint effects of radiation and hepatitis-C virus on chronic liver disease. J Radiol Prot. 24:131–145.
  • Cologne JB, Sharp GB, Neriishi K, Verkasalo PK, Land CE, Nakachi K. 2004. Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure. Int J Epidemiol. 33:485–492.
  • Cullings HM, Grant EJ, Egbert SD, Watanabe T, Oda T, Nakamura F, Yamashita T, Fuchi H, Funamoto S, Marumo K, et al. 2017. DS02R1: Improvements to atomic bomb survivors’ input data and implementation of Dosimetry System 2002 (DS02) and resulting changes in estimated doses. Health Phys. 112:56–97.
  • Good PI. 2006. Resampling methods. 3rd ed. Boston: Birkhäuser.
  • Grant EJ, Neriishi K, Cologne J, Eguchi H, Hayashi T, Geyer S, Izumi S, Nishi N, Land C, Stevens RG, et al. 2011. Associations of ionizing radiation and breast cancer-related serum hormone and growth factor levels in cancer-free female A-bomb survivors. Radiat Res. 176:678–687.
  • Greenland S. 1983. Tests for interaction in epidemiologic studies: a review and a study of power. Stat Med. 2:243–251.
  • Hafeman DM, Schwartz S. 2009. Opening the black box: a motivation for the assessment of mediation. Int J Epidemiol. 38:838–845.
  • Hayashi T, Morishita Y, Kubo Y, Kusunoki Y, Hayashi I, Kasagi F, Hakoda M, Kyoizumi S, Nakachi K. 2005. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am J Med. 118:83–86.
  • Henrich JB, Hughes JP, Kaufman SC, Brody DJ, Curtin LR.2006. Limitations of follicle-stimulating hormone in assessing menopause status: findings from the National Health and Nutrition Examination Survey (NHANES 1999–2000). Menopause. 13:171–177.
  • Hill DA, Gilbert E, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, et al. 2005. Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood. 106:3358–3365.
  • Holmberg E. 2001. Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy. Br J Cancer. 85:362–366.
  • Howe GR, McLaughlin J. 1996. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res. 145:694–707.
  • Huang B, Sivaganesan S, Succop P, Goodman E. 2004. Statistical assessment of mediational effects for logistic mediational models. Statist Med. 23:2713–2728.
  • Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE.2000. A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev. 9:575–579.
  • Land CE, Hayakawa N, Machado SG, Yamada Y, Pike MC, Akiba S, Tokunaga M. 1994a. A case-control interview study of breast cancer among Japanese A-bomb survivors. I. Main effects. Cancer Causes Control. 5:157–165.
  • Land CE, Hayakawa N, Machado SG, Yamada Y, Pike MC, Akiba S, Tokunaga M. 1994b. A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose. Cancer Causes Control. 5:167–176.
  • Lange T, Hansen JV. 2011. Direct and indirect effects in a survival context. Epidemiology. 22:575–581.
  • Lange T, Vansteelandt S, Bekaert M. 2012. A simple unified approach for estimating natural direct and indirect effects. Am J Epidemiol. 176:190–195.
  • Langholz B. 2005. Case-control study, nested. In: Armitage P, Colton P, editors. Encyclopedia of biostatistics. 2nd ed. West Sussex: John Wiley & Sons Ltd; p. 646–655.
  • Langholz B, Borgan OR. 1995. Counter-matching: a stratified nested case-control sampling method. Biometrika. 82:69–79.
  • Mabuchi K, Soda M, Ron E, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Preston DL, Thompson DE. 1994. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res. 137(2 Suppl):S1–S16.
  • McDougall JA, Sakata R, Sugiyama H, Grant E, Davis S, Nishi N, Soda M, Shimizu Y, Tatsukawa Y, Kasagi F. et al. 2010. Timing of menarche and first birth in relation to risk of breast cancer in A-bomb survivors. Cancer Epidemiol Biomarkers Prev. 19:1746–1754.
  • Ostroumova E, Preston DL, Ron E, Krestinina L, Davis FG, Kossenko M, Akleyev A.2008. Breast cancer incidence following low-dose rate environmental exposure: Techa River Cohort, 1956–2004. Br J Cancer. 99:1940–1945.
  • Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant EJ, Sakata R, Sugiyama H, Kodama K. 2012. Studies of the mortality of atomic bomb survivors, Report 14, 1950–2003: an overview of cancer and noncancer diseases. Radiat Res. 177:229–243.
  • Pearl J. 2009. Causal inference in statistics: an overview. Statist Surv. 3:96–146.
  • Pedram A, Razandi M, Evinger AJ, Lee E, Levin ER. 2009. Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. Mol Biol Cell. 20:3374–3389.
  • Pierce DA, Stram DO, Vaeth M. 1990. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res. 123:275–284.
  • Preston DL, Lubin JH, Pierce DA, McConney ME, Shilnikova NS. 2015. Epicure user guide. 12th ed. Ottawa: Risk Sciences International.
  • Preston DL, Krestinina LY, Sokolnikov ME, Ron E, Davis FG, Ostroumova EV, Gilbert ES. 2010. How much can we say about site-specific cancer radiation risks? Radiat Res. 174:816–824.
  • Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K. 2007. Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res. 168:1–64.
  • R Core Team. 2014. R: A language and environment for statistical computing. 2nd ed. Vienna, Austria. [accessed 2007 Nov 6]. http://www.R-project.org.
  • Ronckers CM, Doody MM, Lonstein JE, Stovall M, Land CE. 2008. Multiple diagnostic X-rays for spine deformities and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 17:605–613.
  • Russo IH, Russo J. 2011. Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia. 16:221–233.
  • Russo J, Moral R, Balogh GA, Mailo D, Russo IH. 2005. The protective role of pregnancy in breast cancer. Breast Cancer Res. 7:131–142.
  • Segaloff A, Maxfield WS. 1971. The synergism between radiation and estrogen in the production of mammary cancer in the rat. Cancer Res. 31:166–168.
  • Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, Grant EJ, Sugiyama H, Sakata R, Moriwaki H, et al. 2010. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ. 340:b5349.
  • Sigurdson AJ, Doody MM, Rao RS, Freedman DM, Alexander BH, Hauptmann M, Mohan AK, Yoshinaga S, Hill DA, Tarone R, et al. 2003. Cancer incidence in the US radiologic technologists health study, 1983-1998. Cancer. 97:3080–3089.
  • Solleveld HA, van Zwieten MJ, Broerse JJ, Hollander CF. 1986. Effects of X-irradiation, ovariohysterectomy and estradiol-17 beta on incidence, benign/malignant ratio and multiplicity of rat mammary neoplasms-a preliminary report. Leuk Res. 10:755–759.
  • SRL (Tokyo Special Reference Laboratories, Inc). 2013.卵胞刺激ホルモン (FSH) 基準値 [Follicle-stimulating hormone (FSH) reference levels]. [accessed 2013 Oct 24] http://www.srl.info/srlinfo/kensa_ref_CD/otherdata/06-6118.html Japanese.
  • Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, et al. 1994. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958–1987. Radiat Res. 137:S17–S67.
  • Tokunaga M, Land CE, Tokuoka S, Nishimori I, Soda M, Akiba S. 1994. Incidence of female breast cancer among atomic bomb survivors, 1950–1985. Radiat Res. 138:209–223.
  • VanderWeele TJ, Vansteelandt S. 2010. Odds ratios for mediation analysis for a dichotomous outcome. Am J Epidemiol. 172:1339–1348.
  • Wong FL, Yamada M, Sasaki H, Kodama K, Hosoda Y. 1999. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors. Radiat Res. 151:736–746.
  • Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. 2004. Noncancer disease incidence in atomic bomb survivors, 1958–1998. Radiat Res. 161:622–632.
  • Young RW, Kerr GD, editors. 2005. Reassessment of the atomic bomb radiation dosimetry for Hiroshima and Nagasaki – dosimetry system 2002. Hiroshima: Radiation Effects Research Foundation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.